NCT02534285

Brief Summary

The investigators hypothesize that the noise level in the operating theatre influences the patients' requirements of anesthetics. Study subject are patients undergoing abdominal surgery in combined general and epidural anesthesia. Analgesia is maintained by epidural injections of sufentanil and ropivacaine whereas general anesthesia is maintained using the inhalational anesthetic desflurane. Desflurane requirements are adjusted using neuromonitoring (BIS-Index). Intraoperative noise levels are recorded. Patients are randomized to receive hearing protections or not.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

August 25, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 27, 2015

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
3.8 years until next milestone

Results Posted

Study results publicly available

August 6, 2020

Completed
Last Updated

August 6, 2020

Status Verified

July 1, 2020

Enrollment Period

1.3 years

First QC Date

August 25, 2015

Results QC Date

July 21, 2020

Last Update Submit

July 21, 2020

Conditions

Keywords

Anesthesia, InhalationHearingNoise, Occupational

Outcome Measures

Primary Outcomes (1)

  • Requirements of the Inhalational Anesthetic Desflurane, Measured in Expiratory Volume Percentage, to Maintain a BIS-Index Triggered Depth of Anesthesia

    Aimed BIS-index is 50, desflurane is measured in expiratory volume percentage

    one hour

Secondary Outcomes (1)

  • Awareness Using a Structured Interview ("Modified Brice Questionnaire")

    1 day

Study Arms (2)

Control

SHAM COMPARATOR

Patients of the control group receive a Sham hearing protection with no effect on noise attenuation.

Device: hearing protection

Intervention

ACTIVE COMPARATOR

Patients of the Intervention group receive a Hearing protection with a noise attenuation of 20-45 decibel.

Device: hearing protection

Interventions

Attenuation of hearing during surgery

Also known as: PeltorTM OptimeTM III H540A, 3M, Värnamo, Sweden
ControlIntervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • full contractual capability
  • written informed consent
  • abdominal surgery in combined general/epidural anesthesia
  • position during surgery: supine
  • clinically normal hearing

You may not qualify if:

  • history of psychiatric disease
  • history of intraoperative awareness
  • clinically impaired Hearing
  • contraindication for placing an epidural catheter

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital, Dept. of Anesthesia

Dresden, 01307, Germany

Location

Related Links

MeSH Terms

Conditions

Respiratory Aspiration

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Prof. Dr. Matthias Hübler
Organization
Technical University Dresden, Dept. of Anaesthesiology

Study Officials

  • Matthias Hübler, MD

    Consultant Dept. of Anesthesia; University Hospital Dresden; Technische Universität Dresden

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 25, 2015

First Posted

August 27, 2015

Study Start

August 1, 2015

Primary Completion

November 1, 2016

Study Completion

November 1, 2016

Last Updated

August 6, 2020

Results First Posted

August 6, 2020

Record last verified: 2020-07

Locations